Monoclonal antibody applications in travel medicine
Abstract For decades, immunoglobulin preparations have been used to prevent or treat infectious diseases. Since only a few years, monoclonal antibody applications (mAbs) are taking flight and are increasingly dominating this field. In 2014, only two mAbs were registered; end of October 2023, more th...
Main Authors: | Hanna K. de Jong, Martin P. Grobusch |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Tropical Diseases, Travel Medicine and Vaccines |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40794-023-00212-x |
Similar Items
-
Preventing diseases in round-the-world travelers: a contemporary challenge for travel medicine advice
by: Karis Maria de Pinho Rodrigues, et al. -
Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
by: Serena Vita, et al.
Published: (2022-08-01) -
Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study
by: Pietro Ferrara, et al.
Published: (2018-04-01) -
Insights into the design of an improved PfRH5 malaria immunogen using vaccine-induced monoclonal antibodies
by: Alanine, DGW
Published: (2017) -
Monoclonal Antibodies as Tools to Combat Fungal Infections
by: Sebastian Ulrich, et al.
Published: (2020-02-01)